☆ 4.8 Article

Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer's disease

FRONTIERS IN IMMUNOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Acoustics

Transcranial Sonography Findings in Alzheimer's Disease: A New Imaging Biomarker

Rezzak Yilmaz et al.

Summary: Transcranial sonography (TCS) may serve as an alternative imaging tool for assessing MTL atrophy and ventricular enlargement in patients unable to undergo MRI scanning, offering a practical and cost-effective option for screening and follow-up of individuals with AD.

ULTRASCHALL IN DER MEDIZIN (2021)

Add to Collection

Review Clinical Neurology

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches

Alberto Serrano-Pozo et al.

Summary: The APOE ε4 allele and ε2 allele are respectively the strongest genetic risk factor and protective factor for Alzheimer's disease. While therapies targeting APOE are currently unavailable, recent research has expanded our understanding of APOE pathogenesis to include multiple pathological processes, offering valuable insights for therapy development.

LANCET NEUROLOGY (2021)

Add to Collection

Article Neurosciences

Peripheral Markers of Vascular Endothelial Dysfunction Show Independent but Additive Relationships with Brain-Based Biomarkers in Association with Functional Impairment in Alzheimer's Disease

Jonathan D. Drake et al.

Summary: The study found that plasma-based vascular biomarkers, particularly VCAM-1 and ICAM-1, were associated with Alzheimer's disease (AD) and clinical impairment. VCAM-1 was linked with clinical dementia rating sum-of-boxes (CDR-SB) scores, with the APOE epsilon 4 genotype modifying this relationship. Additionally, combining VCAM-1 and cerebrospinal fluid (CSF) biomarkers showed independent associations with AD-related clinical impairment.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Add to Collection

Review Medicine, General & Internal

Alzheimer's disease

Philip Scheltens et al.

Summary: Alzheimer's disease is projected to see a significant increase in prevalence in the future, with genetics playing a key role. Novel biomarkers and lifestyle-based prevention trials show promising therapeutic potential. Promising pharmacological treatments are advancing in clinical trials, targeting amyloid beta, tau, and inflammation.

LANCET (2021)

Add to Collection

Review Clinical Neurology

New insights into atypical Alzheimer's disease in the era of biomarkers

Jonathan Graff-Radford et al.

Summary: Most Alzheimer's disease patients present with memory problems, but a significant proportion of young-onset cases exhibit atypical symptoms like visual, language, executive, behavioral, or motor issues. With advancements in biomarkers and new diagnostic criteria, early detection and tailored treatment plans are now becoming more accessible for these individuals, offering them better care and support. Research into atypical Alzheimer's has unveiled diverse neuropathology across the disease spectrum, providing insights into the vulnerability of different brain networks and potentially impacting understanding of typical late-onset Alzheimer's disease.

LANCET NEUROLOGY (2021)

Add to Collection

Article Geriatrics & Gerontology

Repetitive Transcranial Magnetic Stimulation for Alzheimer's Disease Based on Apolipoprotein E Genotyping: Protocol for a Randomized Controlled Study

Naili Wei et al.

Summary: Currently, there is a lack of effective treatment strategies for Alzheimer's disease (AD) and repetitive transcranial magnetic stimulation (rTMS) can improve cognitive function in AD patients, but the effectiveness may vary depending on individual differences related to different apolipoprotein E (APOE) genotypes. Published clinical studies are highly heterogeneous, highlighting the need for well-developed randomized controlled trials (RCT) and precise treatment strategies.

FRONTIERS IN AGING NEUROSCIENCE (2021)

Add to Collection

Article Clinical Neurology

Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study

Elisabeth H. Thijssen et al.

Summary: Plasma tau phosphorylated at threonine 217 (p-tau217) and plasma tau phosphorylated at threonine 181 (p-tau181) showed excellent diagnostic performance in distinguishing patients with Alzheimer's disease syndromes from other neurodegenerative disorders. P-tau217 outperformed p-tau181 in differentiating Alzheimer's disease syndromes from FTLD syndromes, indicating amyloid-PET positivity, and showing stronger correlations with tau-PET signal.

LANCET NEUROLOGY (2021)

Add to Collection

Article Clinical Neurology

Admixture mapping reveals the association between Native American ancestry at 3q13.11 and reduced risk of Alzheimer's disease in Caribbean Hispanics

Andrea R. V. R. Horimoto et al.

Summary: Genome-wide analysis of Alzheimer's disease in Caribbean Hispanics identified a significant association with chromosome 3q13.11, driven by a protective effect conferred by Native American ancestry. This study highlights the relationship between AD and multiple genes at 3q13.11, showcasing the utility of genetic ancestry diversity via admixture mapping for new insights into AD.

ALZHEIMERS RESEARCH & THERAPY (2021)

Add to Collection

Correction Clinical Neurology

APOE and Alzheimer's disease: advances in genetics, pathophysiology, and therapeutic approaches (vol 20, pg 68, 2021)

Alberto Serrano-Pozo et al.

LANCET NEUROLOGY (2021)

Add to Collection

Article Neurosciences

Neutrophil adhesion in brain capillaries reduces cortical blood flow and impairs memory function in Alzheimer's disease mouse models

Jean C. Cruz Hernandez et al.

NATURE NEUROSCIENCE (2019)

Add to Collection

Article Biochemistry & Molecular Biology

Aged blood impairs hippocampal neural precursor activity and activates microglia via brain endothelial cell VCAM1

Hanadie Yousef et al.

NATURE MEDICINE (2019)

Add to Collection

Article Immunology

ALCAM Mediates DC Migration Through Afferent Lymphatics and Promotes Allospecific Immune Reactions

Ann-Helen Willrodt et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection

Article Cell Biology

Activated leukocyte cell adhesion molecule regulates B lymphocyte migration across central nervous system barriers

Laure Michel et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Add to Collection

Review Cell Biology

Neuroinflammation in mild cognitive impairment and Alzheimer's disease: A meta-analysis

Steven Bradburn et al.

AGEING RESEARCH REVIEWS (2019)

Add to Collection

Review Gerontology

Can MoCA and MMSE Be Interchangeable Cognitive Screening Tools? A Systematic Review

Gloria S. A. Siqueira et al.

GERONTOLOGIST (2019)

Add to Collection

Article Geriatrics & Gerontology

Screening an elderly hearing impaired population for mild cognitive impairment using Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA)

Magdalene Yeok Leng Lim et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2018)

Add to Collection

Article Neurosciences

Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease

Srikant Rangaraju et al.

MOLECULAR NEURODEGENERATION (2018)

Add to Collection

Review Medicine, General & Internal

Biomarkers for Alzheimer's disease: current status and prospects for the future

K. Blennow et al.

JOURNAL OF INTERNAL MEDICINE (2018)

Add to Collection

Article Clinical Neurology

Blood-based NfL A biomarker for differential diagnosis of parkinsonian disorder

Oskar Hansson et al.

NEUROLOGY (2017)

Add to Collection

Review Hematology

Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation

Natalia Reglero-Real et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)

Add to Collection

Article Multidisciplinary Sciences

Single-cell RNAseq reveals cell adhesion molecule profiles in electrophysiologically defined neurons

Csaba Foldy et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Add to Collection

Editorial Material Medicine, General & Internal

The Need for Early Detection and Treatment in Alzheimer's Disease

[Anonymous]

EBIOMEDICINE (2016)

Add to Collection

Article Clinical Neurology

APOE effect on Alzheimer's disease biomarkers in older adults with significant memory concern

Shannon L. Risacher et al.

ALZHEIMERS & DEMENTIA (2015)

Add to Collection

Review Pathology

Genetic diagnosis and prognosis of Alzheimer's disease: challenges and opportunities

Christiane Reitz

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2015)

Add to Collection

Review Clinical Neurology

Neuroinflammation in Alzheimer's disease

Michael T. Heneka et al.

LANCET NEUROLOGY (2015)

Add to Collection

Review Clinical Neurology

CSF Aβ1-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease

Simone Lista et al.

ALZHEIMERS & DEMENTIA (2014)

Add to Collection

Article Oncology

Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction

Chie Kudo-Saito et al.

CANCER RESEARCH (2013)

Add to Collection

Review Clinical Neurology

Review: Systemic inflammation and Alzheimer's disease

C. Holmes

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal

Chongxiu Sun et al.

CIRCULATION RESEARCH (2012)

Add to Collection

Review Clinical Neurology

Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria

Bruno Dubois et al.

LANCET NEUROLOGY (2007)

Add to Collection

Article Clinical Neurology

Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment

ESC Korf et al.

NEUROLOGY (2004)

Add to Collection

Article Cell Biology

Neural cell adhesion molecule promotes accumulation of TGN organelles at sites of neuron-to-neuron contacts

V Sytnyk et al.

JOURNAL OF CELL BIOLOGY (2002)

Add to Collection

© Peeref 2019-2024. All rights reserved.